Daiwa SMBC Capital - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $69,369.49 +2.77%
Ethereum $2,422.79 +0.02%
BNB $564.42 +2.47%
Optimism $1.41 +6.33%
Arbitrum $0.49 +2.94%
Solana $166.53 +5.29%
Polygon $0.30 +3.48%
Cosmos $4.18 +6.95%
Avalanche $23.99 +4.82%

Bitcoin $69,369.49 +2.77%
Ethereum $2,422.79 +0.02%
BNB $564.42 +2.47%
Optimism $1.41 +6.33%
Arbitrum $0.49 +2.94%
Solana $166.53 +5.29%
Polygon $0.30 +3.48%
Cosmos $4.18 +6.95%
Avalanche $23.99 +4.82%

Daiwa SMBC Capital

investment firm

Summary
Investments
Exits
Employees

About

Daiwa SMBC Capital is a venture capital firm that finances later stage and private equity investments.

Tokyo,Tokyo,Japan

Highlights

Lead Investments

Employee Profiles

Details

Operating Status: Active
Also Known As: 大和SMBCキャピタル
Investor Type: Venture Capital

Daiwa SMBC Capital is a venture capital firm based in Tokyo that finances later stage and private equity investments.

Investments

Number of Investments

Number of Lead Investments

7

2

Daiwa SMBC Capital has made 7 investments. Their most recent investment was on Feb 1, 2012, when REGiMMUNE raised $5M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Feb 1, 2012 REGiMMUNE	Series C	$5M	Biopharma	Yes
Jul 7, 2010 Gene Techno Science	Series Unknown	¥507.90M	Biopharma	—
Oct 15, 2008 100e.com	Series B	$8M	Cloud Computing	Yes
May 15, 2007 NexWave Solutions	Series C	$5M	Consumer Electronics	—
Feb 12, 2007 Picsel Technologies	Series C	$46.50M	Embedded Software	—

Show More

Employee Profiles

Number of Employee Profiles

1

Daiwa SMBC Capital has 1 current employee profiles, including Executive Kawasaki Kenichi

Kawasaki Kenichi

Executive

Exits

Daiwa SMBC Capital has had 3 exits. Daiwa SMBC Capital most notable exits include FibroGen , Gene Techno Science

Date	Company Name	Exit Type	Industry
Nov 21, 2014	FibroGen	IPO	Biopharma	Detail
Nov 30, 2012	Gene Techno Science	M&A	Biopharma	Detail
May 17, 2011	SiGe Semiconductor	M&A	Consumer Electronics	Detail